1. Home
  2. IMXI vs RGNX Comparison

IMXI vs RGNX Comparison

Compare IMXI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • RGNX
  • Stock Information
  • Founded
  • IMXI 1994
  • RGNX 2008
  • Country
  • IMXI United States
  • RGNX United States
  • Employees
  • IMXI N/A
  • RGNX N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IMXI Technology
  • RGNX Health Care
  • Exchange
  • IMXI Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • IMXI 414.7M
  • RGNX 451.1M
  • IPO Year
  • IMXI N/A
  • RGNX 2015
  • Fundamental
  • Price
  • IMXI $13.95
  • RGNX $10.69
  • Analyst Decision
  • IMXI Buy
  • RGNX Strong Buy
  • Analyst Count
  • IMXI 5
  • RGNX 8
  • Target Price
  • IMXI $19.60
  • RGNX $28.50
  • AVG Volume (30 Days)
  • IMXI 320.2K
  • RGNX 501.4K
  • Earning Date
  • IMXI 11-07-2025
  • RGNX 11-05-2025
  • Dividend Yield
  • IMXI N/A
  • RGNX N/A
  • EPS Growth
  • IMXI N/A
  • RGNX N/A
  • EPS
  • IMXI 1.65
  • RGNX N/A
  • Revenue
  • IMXI $642,149,000.00
  • RGNX $155,782,000.00
  • Revenue This Year
  • IMXI N/A
  • RGNX $203.27
  • Revenue Next Year
  • IMXI $1.87
  • RGNX $0.58
  • P/E Ratio
  • IMXI $8.51
  • RGNX N/A
  • Revenue Growth
  • IMXI N/A
  • RGNX 74.95
  • 52 Week Low
  • IMXI $8.58
  • RGNX $5.04
  • 52 Week High
  • IMXI $22.37
  • RGNX $12.22
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 46.50
  • RGNX 65.40
  • Support Level
  • IMXI $13.91
  • RGNX $9.55
  • Resistance Level
  • IMXI $14.28
  • RGNX $11.00
  • Average True Range (ATR)
  • IMXI 0.12
  • RGNX 0.50
  • MACD
  • IMXI -0.13
  • RGNX 0.12
  • Stochastic Oscillator
  • IMXI 5.69
  • RGNX 86.73

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: